Bionano Announces OGM Roadshow, TOUR, which Provides Education on the Company’s Workflow and Helps Build a Community of Users

SAN DIEGO, July 31, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the successful launch of its optical genome mapping (OGM) roadshow, Bionano TOUR, a series of regional customer-led events that showcase the latest advancements to the OGM workflow and demonstrate applicable research applications.

Bionano TOUR provides an immersive in-person experience for attendees, combining informative demonstrations of the OGM workflow, the Ionic system and VIA software from internal Bionano experts with presentations from current OGM users who have implemented the workflow for research in hematological malignancies, genetic disease, cell bioprocessing, and other applications. By bringing together industry experts, thought leaders, and technical product specialists, the event serves as a platform for attendees to explore ways OGM might provide new cytogenetic insights in their research and address critical gaps that are left unanswered by other genome analysis products. Moreover, TOUR acts as a catalyst for building strong, locally supported OGM communities, allowing users to connect with their peers and helping to build relationships amongst current and potential customers.

"We are really pleased to see how enthusiastic scientists and clinicians are about TOUR, which has visited 8 U.S. cities so far with more planned for this fall," said Erik Holmlin, Ph.D., president and chief executive officer of Bionano. "Bionano Symposium, which gathers the global community of OGM users and prospective users in a virtual event that lasts for a week in January, has been enormously successful in showing how the community uses OGM in their research. TOUR takes that same level of in-depth OGM experience with users to live, in-person events offering engagement with OGM experts to existing users. TOUR also provides the opportunity for new potential OGM users to learn what OGM is all about."

For more information on upcoming events, visit www.bionano.com/tour-2023.

About Bionano

Bionano is a provider of genomic analysis solutions that can help reveal answers to challenging genetic questions. Our mission is to transform the way the world sees the genome through optical genome mapping (OGM). Our OGM solutions allow scientists and clinical researchers the ability to see and discover structural variations in a way unmatched by traditional cytogenetic techniques. Our products additionally include an industry-leading, platform-agnostic software solution, which integrates OGM, next-generation sequencing and microarray data in one consolidated view, and nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. Our Lineagen, Inc., d/b/a Bionano Laboratories, business provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. To learn more, visit bionano.com and connect with us on Twitter,  LinkedIn, Instagram,  and YouTube.